| ZYMEWORKS DL-,00001 |
| USA |
| Gesundheit |
| US98985Y1082 / A3DSSN |
| ZA8 (Frankfurt) / ZYME (NASDAQ) |
| FRA:ZA8, ETR:ZA8, ZA8:GR, NASDAQ:ZYME |
| - |
| https://www.zymeworks.com.. |
|
Zymeworks Inc. is a biotechnology company that focuses on innovating biotherapeutics for the treatment of cancer and autoimmune diseases. The company's core mission revolves around developing novel, m..
>Volltext.. |
| 1486.52 Mio. EUR |
| 1288.25 Mio. EUR |
| 113.83 Mio. EUR |
| -48.94 Mio. EUR |
| -53.69 Mio. EUR |
| -0.71 EUR |
| 16 Mio. EUR |
| 54.88 Mio. EUR |
| -52.93 Mio. EUR |
| 5.99 |
| 105.15% |
| 47.06% |
| - |
| - |
| - |
| - |
| ZYMEWORKS |
| 02.03.26 |